Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab with TS-ONE and Cisplatin in HER2-positive advanced gastric cancer
NCT01736410Phase 2Completed
- Sponsor
- National Cancer Centre Singapore
- Start
- May 2010
- Primary completion
- Apr 2013
- Countries
- 1
01
Overview
Phase 2, open-label trial of trastuzumab in gastric cancer (GC), sponsored by National Cancer Centre Singapore. Started May 2010; status: completed.
02
Drugs
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01736410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01736410.